These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3612682)

  • 1. Inhibitors of dopamine beta-hydroxylase. 3. Some 1-(pyridylmethyl)imidazole-2-thiones.
    Ross ST; Kruse LI; Ohlstein EH; Erickson RW; Ezekiel M; Flaim KE; Sawyer JL; Berkowitz BA
    J Med Chem; 1987 Aug; 30(8):1309-13. PubMed ID: 3612682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine beta-hydroxylase.
    McCarthy JR; Matthews DP; Broersma RJ; McDermott RD; Kastner PR; Hornsperger JM; Demeter DA; Weintraub HJ; Whitten JP
    J Med Chem; 1990 Jul; 33(7):1866-73. PubMed ID: 2362264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisubstrate inhibitors of dopamine beta-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding site.
    Kruse LI; Kaiser C; DeWolf WE; Frazee JS; Ross ST; Wawro J; Wise M; Flaim KE; Sawyer JL; Erickson RW
    J Med Chem; 1987 Mar; 30(3):486-94. PubMed ID: 3820219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some benzyl-substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors of dopamine beta-hydroxylase. 4. Structure-activity relationships at the copper binding site.
    Kruse LI; Kaiser C; DeWolf WE; Finkelstein JA; Frazee JS; Hilbert EL; Ross ST; Flaim KE; Sawyer JL
    J Med Chem; 1990 Feb; 33(2):781-9. PubMed ID: 2299645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisubstrate inhibitors of dopamine beta-hydroxylase. 1. Some 1-phenyl and 1-phenyl-bridged derivatives of imidazole-2-thione.
    Kruse LI; Kaiser C; DeWolf WE; Frazee JS; Garvey E; Hilbert EL; Faulkner WA; Flaim KE; Sawyer JL; Berkowitz BA
    J Med Chem; 1986 Dec; 29(12):2465-72. PubMed ID: 3783606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-(substituted-benzyl)imidazole-2(3H)-thione inhibitors of dopamine beta-hydroxylase.
    Burke BJ; Hopfinger AJ
    J Med Chem; 1990 Jan; 33(1):274-81. PubMed ID: 2296023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Sherman SS; Erickson R; DeWolf WE; Berkowitz BA
    J Pharmacol Exp Ther; 1987 May; 241(2):554-9. PubMed ID: 3572812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase.
    Stanley WC; Li B; Bonhaus DW; Johnson LG; Lee K; Porter S; Walker K; Martinez G; Eglen RM; Whiting RL; Hegde SS
    Br J Pharmacol; 1997 Aug; 121(8):1803-9. PubMed ID: 9283721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.
    Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P
    Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical importance and synthetic strategies for imidazolidine-2-thione and imidazole-2-thione derivatives.
    Savjani JK; Gajjar AK
    Pak J Biol Sci; 2011 Dec; 14(24):1076-89. PubMed ID: 22335047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopamine beta-hydroxylase.
    Kruse LI; Kaiser C; DeWolf WE; Frazee JS; Erickson RW; Ezekiel M; Ohlstein EH; Ruffolo RR; Berkowitz BA
    J Med Chem; 1986 Jun; 29(6):887-9. PubMed ID: 3712378
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of nepicastat (RS-25560-197), a novel dopamine beta-hydroxylase inhibitor.
    Stanley WC; Lee K; Johnson LG; Whiting RL; Eglen RM; Hegde SS
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):963-70. PubMed ID: 9641484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-beta-hydroxylase inhibition: a novel sympatho-modulatory approach for the treatment of congestive heart failure.
    Hegde SS; Friday KF
    Curr Pharm Des; 1998 Dec; 4(6):469-79. PubMed ID: 10197057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dopamine beta-hydroxylase inhibition on systemic hemodynamics in conscious, spontaneously hypertensive rats.
    Gellai M; DeWolf RE; Ruffolo RR
    Pharmacology; 1990; 41(2):82-90. PubMed ID: 2263673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.
    Pires NM; Igreja B; Moura E; Wright LC; Serrão MP; Soares-da-Silva P
    Hypertens Res; 2015 Sep; 38(9):605-12. PubMed ID: 25854989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
    J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation.
    Devoto P; Fattore L; Antinori S; Saba P; Frau R; Fratta W; Gessa GL
    Addict Biol; 2016 Jan; 21(1):61-71. PubMed ID: 25135633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine β-hydroxylase inhibitor.
    Igreja B; Wright LC; Soares-da-Silva P
    J Am Soc Hypertens; 2016 Mar; 10(3):207-16. PubMed ID: 26803288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new route to the imidazole-2-thiones from 2-thiohydantoins. Implications in the study of ergothioneine.
    Scott JE; Henderson G
    Biochem J; 1968 Sep; 109(2):209-15. PubMed ID: 5679364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.